logo

Sonoma Pharmaceuticals Inc’s Mixed Bag: Up 48.42% in 6 Months, Up 34.71% in 30 Days

Sonoma Pharmaceuticals Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $9.37 on 07/11/24 and the lowest value was $1.75 on 04/07/25.

52-week price history of SNOA Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Sonoma Pharmaceuticals Inc’s current trading price is -54.88% away from its 52-week high, while its distance from the 52-week low is 141.71%. The stock’s price range during this period has spanned from $1.75 to $9.37. In the Healthcare sector, the Sonoma Pharmaceuticals Inc’s shares surpassed a trading volume of approximately 1.18 million for the day, which was noticeably lower compared to the average daily volume of 9.2.64 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Sonoma Pharmaceuticals Inc (SNOA) has experienced a quarterly rise of 48.94% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 6.83M and boasts a workforce of 172 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.67, with a change in price of +1.44. Similarly, Sonoma Pharmaceuticals Inc recorded 1,710,983 in trading volume during the last 100 days, posting a change of +51.61%.

Examining SNOA’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for SNOA stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.

SNOA Stock Stochastic Average

Today’s raw stochastic average for Sonoma Pharmaceuticals Inc over the last 50 days is 91.51%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 97.25%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 91.06% and 70.34%, respectively.

SNOA Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The metric has seen a significant gain of 57.25% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 48.42%. Over the past 30 days, the price of SNOA has fallen by 34.71%. And in the last five days, it has surged by 83.91%.

Most Popular